June 5, 2022 SanaCurrents Portfolio Update: APLS files NDA, IMUX UC drug falters in phase II topline, plus VERA and ACET This content is for members only
February 20, 2022 Vera Therapeutics’ (VERA) phase II kidney transplant drug Probability Sentiment This content is for members only